TranS1 Inc. (TSON: Quote) announced Monday morning that the American Medical Association Current Procedural Terminology Panel has voted to approve an application for a Category I CPT code for L5-S1 spinal fusion, utilizing TranS1's pre-sacral interbody fusion approach with its AxiaLIF implant.
TranS1 gapped up sharply Monday, but traded in a range for the majority of the session. The stock closed up by 0.79 at $4.07, with volume at over an 11-month high. TranS1 jumped to nearly a 6-month high.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org